STOCK TITAN
  1. Home
  2. Sec-filings
  3. RARE
  4. [S-8] Ultragenyx Pharmaceutical Inc. Employee Benefit Plan Registration

[S-8] Ultragenyx Pharmaceutical Inc. Employee Benefit Plan Registration

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
S-8

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock RARE logo
Ultragenyx Pharm

NASDAQ:RARE

RARE Rankings

#2542 Ranked by Market Cap
N/A Ranked by Dividends

RARE Latest News

Aug 5, 2025
Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update
Jul 31, 2025
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
Jul 30, 2025
Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update
Jul 18, 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 11, 2025
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

RARE Latest SEC Filings

Aug 5, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jul 31, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jul 11, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jul 9, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Jun 27, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event

RARE Stock Data

2.70B
92.34M
3.2%
99.74%
9.31%
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO